Figure credits: Pixabay

The human gut microbiome is a complex and dynamic community of microorganisms that has been associated with a variety of health conditions, including various forms of cancer. Ovarian cancer, in particular, is one of the leading causes of cancer-related deaths in women and is known for its difficult diagnosis and resistance to treatments. A recent study led by Chaoyang Sun and Gang Chen of Huazhong University of Science and Technology investigated the relationship between the gut microbiome and ovarian cancer.

The study compared the fecal samples of 40 women with ovarian cancer to an equal number of women with a benign form of the disease. The researchers found that the composition of the gut microbiome in women with ovarian cancer differed from that of the control group. In particular, they observed that the levels of the bacteria Akkermansia were reduced in women with ovarian cancer. The transfer of gut microbes from patients with ovarian cancer to mice with the same type of tumor accelerated the tumor’s growth, while the addition of Akkermansia bacteria to the transplant of the gut microbiome slowed down its progression.

These findings suggest that the alterations in the gut microbiome, especially the reduction in Akkermansia, is closely related to the progression of ovarian cancer. Further experiments showed that the addition of Akkermansia to the gut microbiome transplant restored the intestinal barrier function, activated T lymphocytes, and increased the levels of the short-chain fatty acid acetate.

The results of this study suggest a connection between the gut microbiome and the immune surveillance of ovarian cancer and could provide valuable insights for the development of new therapeutic approaches. However, it is important to note that more research is needed to fully understand the relationship between the gut microbiome and ovarian cancer and to determine the best way to manipulate the microbiome to achieve the desired effects.

For more info: